The debt-for-equity swap with Streeterville signals ongoing cash constraints and reliance on dilutive financing. With no new cash raised and shares becoming free-trading, near-term selling pressure from Streeterville is likely. Monitor for further note conversions or additional dilutive financing.
Price Chart
Executive Summary
Jaguar Health issued 547,898 common shares to Streeterville Capital in exchange for a $5,049,909.26 reduction in the outstanding balance of its secured promissory note. The exchange, executed under Section 3(a)(9) of the Securities Act, reduces debt by approximately 47% of the original $10.81M note principal. Post-exchange, the company had approximately 1,281,867 shares outstanding, implying dilution of roughly 43% from the exchange shares alone.
Key Facts
- Issued 547,898 shares to Streeterville Capital in exchange for a $5,049,909.26 reduction in the 2025 Note balance.
- Original 2025 Note principal was $10,810,000; the exchange reduces it by ~47%.
- Post-exchange outstanding shares: approximately 1,281,867.
- Exchange shares issued under Section 3(a)(9) exemption; shares are free-trading without restrictive legend.
- No new cash proceeds to the company; the transaction is purely debt-for-equity conversion.
- Streeterville is capped at 9.99% beneficial ownership post-exchange.
Financial Impact
Debt reduction of $5,049,909.26 via issuance of 547,898 shares, representing ~43% dilution relative to the post-exchange share count of 1,281,867.
Risk Factors
- Streeterville may sell the free-trading shares in the open market, creating downward price pressure.
- Remaining note balance of ~$5.76M could be converted into additional shares, further diluting existing holders.
- No new operating capital raised; the company remains dependent on external financing to fund operations.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-400087 |
| Document: d161376dex101.htm | 0001193125-26-400087 |
| Document: 0001193125-26-400087-index-headers.html | 0001193125-26-400087 |
| Document: 0001193125-26-400087-index.html | 0001193125-26-400087 |
| Document: 0001193125-26-400087.txt | 0001193125-26-400087 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | S-3 | $2.04 | awaiting T+60 | — | $2.37 (−16.18%) |
Oct 8, 2026 18d ago | DEF 14A | $4.79 | awaiting T+60 | — | $2.37 (+50.52%) |
Oct 5, 2026 21d ago | 8-K | $4.73 | awaiting T+60 | — | $2.37 (+49.89%) |
Sep 28, 2026 28d ago | 8-K | $6.02 | awaiting T+60 | — | $2.37 (+60.63%) |
Sep 24, 2026 4w ago | SC 13G/A | $7.70 | awaiting T+60 | — | $2.37 (+69.22%) |
Sep 24, 2026 4w ago | 424B5 | $7.06 | awaiting T+60 | — | $2.37 (+66.43%) |
Sep 24, 2026 4w ago | 8-K | $7.06 | awaiting T+60 | — | $2.37 (+66.43%) |
Sep 21, 2026 5w ago | 8-K | $34.46 | awaiting T+60 | — | $2.37 (−93.12%) |
Sep 15, 2026 5w ago | 8-K | $0.2246 | awaiting T+60 | — | $2.37 (−955.21%) |
Sep 3, 2026 7w ago | 424B5 | $10.41 | awaiting T+60 | — | $2.37 (+77.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers